Literature DB >> 22448902

USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus.

G R Nimmo1.   

Abstract

The epidemic of USA300-0114 methicillin-resistant Staphylococcus aureus (MRSA) in the USA has been remarkable for its virulence and for its ability to cause infections in both the community and healthcare settings. Although it has mainly been associated with skin and soft tissue infections, particularly furunculosis, it has also caused severe life-threatening conditions such as necrotizing pneumonia, osteomyelitis, and septic arthritis. This strain or a closely related Latin American variant has now spread to multiple countries on five continents, where associated clinical and epidemiological features have been in keeping with those seen in the USA. Furthermore, it has become the dominant community-associated MRSA strain in five countries. It is now a major international epidemic strain, but whether it will supplant established community-associated strains in other countries remains to be seen.
© 2012 The Author. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22448902     DOI: 10.1111/j.1469-0691.2012.03822.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  70 in total

1.  Autophagy mediates tolerance to Staphylococcus aureus alpha-toxin.

Authors:  Katie Maurer; Tamara Reyes-Robles; Francis Alonzo; Joan Durbin; Victor J Torres; Ken Cadwell
Journal:  Cell Host Microbe       Date:  2015-03-26       Impact factor: 21.023

2.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology.

Authors:  James Q Del Rosso; Ted Rosen; Diane Thiboutot; Guy F Webster; Richard L Gallo; James J Leyden; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

3.  Effects of Tedizolid Phosphate on Survival Outcomes and Suppression of Production of Staphylococcal Toxins in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia.

Authors:  Vien T M Le; Hoan N Le; Marcos Gabriel Pinheiro; Kenneth J Hahn; Mary L Dinh; Kajal B Larson; Shawn D Flanagan; Cedric Badiou; Gerard Lina; Christine Tkaczyk; Bret R Sellman; Binh An Diep
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 4.  Staphylococcus aureus infections: transmission within households and the community.

Authors:  Justin Knox; Anne-Catrin Uhlemann; Franklin D Lowy
Journal:  Trends Microbiol       Date:  2015-04-09       Impact factor: 17.079

5.  An outbreak in intravenous drug users due to USA300 Latin-American variant community-acquired methicillin-resistant Staphylococcus aureus in France as early as 2007.

Authors:  M Sassi; B Felden; M Revest; P Tattevin; Y Augagneur; P-Y Donnio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-02       Impact factor: 3.267

6.  First outbreak of community-acquired MRSA USA300 in France: failure to suppress prolonged MRSA carriage despite decontamination procedures.

Authors:  O Baud; S Giron; C Aumeran; D Mouly; G Bardon; M Besson; J Delmas; B Coignard; A Tristan; F Vandenesch; G Illes; O Lesens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-11       Impact factor: 3.267

7.  Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates.

Authors:  Jorge L Aguilar; Avanish K Varshney; Xiaobo Wang; Lindsay Stanford; Matthew Scharff; Bettina C Fries
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

8.  30-day mortality in UK patients with bacteraemic community-acquired pneumonia.

Authors:  M Melzer; C Welch
Journal:  Infection       Date:  2013-05-24       Impact factor: 3.553

9.  Emergence of Panton-Valentine leucocidin-positive ST8-methicillin-resistant Staphylococcus aureus (USA300 clone) in Korea causing healthcare-associated and hospital-acquired bacteraemia.

Authors:  J Jung; E H Song; S Y Park; S-R Lee; S-J Park; H Sung; M-N Kim; S-H Kim; S-O Lee; S-H Choi; J H Woo; Y S Kim; Y P Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-21       Impact factor: 3.267

10.  High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: evidence for the blurring of community-hospital boundaries.

Authors:  A Tavares; M Miragaia; J Rolo; C Coelho; H de Lencastre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-21       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.